Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Intel Corporation (INTC), Johnson & Johnson (JNJ): This 10-Stock Dividend Strategy Is Trouncing the Dow Jones Industrial Average (.DJI)

Then on Thursday, the Department of Commerce reported that building permits rose to 1.02 million in May, their highest level in nearly five years, which bodes well for the housing market. The final positive factor was on Friday, as consumer sentiment rose far above expectations to a six-year high.

Movers and shakers
The biggest mover this past week among the Dogs of the Dow was Johnson & Johnson (NYSE:JNJ), which rose 2.72%. On Monday, the FDA gave priority review status to the company’s hepatitis-C drug, simeprevir. That’s a good sign, as it puts Johnson & Johnson (NYSE:JNJ)’s drug in the lead to be first to market, ahead of Gilead Sciencescompeting drug sofosbuvir. If you don’t have time to read the company’s annual report, Fool analyst Morgan Housel recently went through it and pointed out five things he learned from reading the annual report.

The article This 10-Stock Dividend Strategy Is Trouncing the Dow originally appeared on Fool.com and is written by Dan Dzombak.

Find Dan Dzombak on Twitter, @DanDzombak, or on his Facebook page, DanDzombak. He has no position in any stocks mentioned. The Motley Fool recommends Intel, Johnson & Johnson, and McDonald’s and owns shares of General Electric, Intel, Johnson & Johnson, and McDonald’s.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.